tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
Comparison · Analytics
DoseFinding vs maplegend
A side-by-side editorial comparison of DoseFinding and maplegend — release velocity, themes, recent moves, and the top alternatives to consider.
DoseFinding vs maplegend: at a glance
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
What is maplegend?
The legend engine mapsf spun out, now covering legend types the parent map package can draw.
maplegend draws the legends for base-R thematic maps, extracted from mapsf so both packages could evolve the legend vocabulary independently. It has been catching up to the map types it has to serve: 0.6.0 added choro_point, choro_line, and choro_symb for choropleth legends rendered on circles, lines, and symbols, following the histogram legend type in 0.4.0. Considerable effort has gone into behaving correctly when the plot aspect ratio is not 1, which required refactoring most of the package in 0.4.0 and still produced a proportional-symbol segment sizing fix in 0.6.3.
DoseFinding vs maplegend: editorial side-by-side
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
maplegend
0.0ANALYTICS
The legend engine mapsf spun out, now covering legend types the parent map package can draw.
◆ Current state
maplegend draws the legends for base-R thematic maps, extracted from mapsf so both packages could evolve the legend vocabulary independently. It has been catching up to the map types it has to serve: 0.6.0 added choro_point, choro_line, and choro_symb for choropleth legends rendered on circles, lines, and symbols, following the histogram legend type in 0.4.0. Considerable effort has gone into behaving correctly when the plot aspect ratio is not 1, which required refactoring most of the package in 0.4.0 and still produced a proportional-symbol segment sizing fix in 0.6.3.
◆ Where it's heading
This is a support library whose backlog is defined by its caller. Every legend type mapsf can produce needs a matching legend renderer, and the release notes are dominated by spacing, offset, and border details — box_cex for symbol spacing, NA box placement in horizontal choropleth legends, text overflow when no_data is set. The shared vocabulary with mapsf is being maintained deliberately, with val_rnd, val_big, and val_dec propagating through legend types release by release. Version numbering is not monotonic in this feed, with 0.4.0 published seconds after 0.5.0.
◆ Prediction
Expect the remaining combined map types to acquire matching legends and the val_* formatting arguments to reach the types that still lack them.
Alternatives to DoseFinding and maplegend
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or maplegend.
Tplyr
Tplyr made clinical summary tables explain where every number came from.
rlistings
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
hoardr
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
riem
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
See all DoseFinding alternatives → · See all maplegend alternatives →
Recent activity from DoseFinding and maplegend
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 2mo agomaplegendContinuous legend formatting and aspect-ratio segment fix
- 4mo agomaplegendChoropleth legends on points, lines and symbols
- 7mo agomaplegendPackage-wide refactor for non-unity aspect ratios, histogram legends
- 7mo agomaplegendSingle-modality legends allowed for typo, symb and prop_line
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agomaplegendAlpha transparency and redraw on device resize
- 1y agomaplegendOffset and symbol sizing aligned with mapsf
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoDoseFindingCompliance update for R-devel
- 3y agoDoseFindingpowMCTBinCount bug fix
Frequently asked questions
What is the difference between DoseFinding and maplegend?
They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and maplegend are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is DoseFinding better than maplegend?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and maplegend are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
What are the best alternatives to maplegend?
Top maplegend alternatives in Analytics are ranked by recent ship velocity. Browse the "maplegend alternatives" section above for the current picks, or visit /alternatives/maplegend for the full list with editorial commentary on each.